Cargando…
Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
PURPOSE: This study investigated the influence of obesity on the clinical course and effect of gonadotropin-releasing hormone analog (GnRHa) treatment in girls with central precocious puberty (CPP). METHODS: Medical records of 182 girls with CPP treated with GnRHa were reviewed. They were divided in...
Autores principales: | Kim, Hye Ryun, Nam, Hyo-Kyoung, Rhie, Young-Jun, Lee, Kee-Hyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Pediatric Endocrinology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769834/ https://www.ncbi.nlm.nih.gov/pubmed/29301187 http://dx.doi.org/10.6065/apem.2017.22.4.259 |
Ejemplares similares
-
Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
por: Chung, Lindsey Yoojin, et al.
Publicado: (2020) -
Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
por: Baek, Joon-Woo, et al.
Publicado: (2014) -
Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment
por: Nam, Hyo-Kyoung, et al.
Publicado: (2017) -
Factors to Predict Positive Results of Gonadotropin Releasing Hormone Stimulation Test in Girls with Suspected Precocious Puberty
por: Nam, Hyo-Kyoung, et al.
Publicado: (2012) -
Thyroid function in girls with central precocious puberty
por: Jung, Geehae, et al.
Publicado: (2019)